Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.61 - $2.49 $140,373 - $573,001
-230,121 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$2.2 - $4.53 $33,816 - $69,630
-15,371 Reduced 6.26%
230,121 $532,000
Q3 2021

Nov 15, 2021

SELL
$3.85 - $5.09 $14,491 - $19,158
-3,764 Reduced 1.51%
245,492 $1.12 Million
Q2 2021

Aug 16, 2021

SELL
$4.03 - $7.57 $15,499 - $29,114
-3,846 Reduced 1.52%
249,256 $1.11 Million
Q1 2021

May 12, 2021

BUY
$6.8 - $9.16 $21,093 - $28,414
3,102 Added 1.24%
253,102 $1.84 Million
Q4 2020

Feb 16, 2021

BUY
$5.29 - $9.1 $1.32 Million - $2.28 Million
250,000 New
250,000 $1.91 Million

About LogicBio Therapeutics, Inc.


  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.